Issue: December 2018
November 09, 2018
2 min watch
Save
Clinician discusses drug penetration technology in Inveltys
Issue: December 2018
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Cataract Surgery in Optometry.
Added to email alerts
You've successfully added Cataract Surgery in Optometry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Cataract Surgery in Optometry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN ANTONIO – Walter Whitley, OD, MBA, FAAO, discusses the amplified technology behind Inveltys that helps the drug penetrate the eye.
Inveltys (loteprednol etabonate ophthalmic suspension 1%) is a twice-daily ocular steroid for the treatment of inflammation and pain after ocular surgery to be approved by the FDA.
Read more from American Academy of Optometry
View allDecember 19, 2024
1 min read
Save
December 18, 2024
1 min read
Save
December 13, 2024
1 min read
Save
December 12, 2024
4 min watch
Save
December 10, 2024
1 min read
Save
December 06, 2024
2 min watch
Save
December 05, 2024
1 min read
Save
December 04, 2024
4 min watch
Save
December 02, 2024
1 min read
Save
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Cataract Surgery in Optometry.
Added to email alerts
You've successfully added Cataract Surgery in Optometry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Cataract Surgery in Optometry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.